Latest Share Purchase Plans News

Bio-Gene Technology Limited has launched a Share Purchase Plan allowing Australian shareholders to invest up to $15,000 at 2.3 cents per share, matching a recent $2.1 million placement. The offer includes free-attaching options, subject to shareholder approval, to support key product development milestones.

Vertex Minerals has raised approximately A$11 million to accelerate underground mining at its high-grade Hill End Gold Project, targeting production by July 2025. The capital raising includes a share placement, convertible loan, and a Share Purchase Plan, positioning the company for strong margins amid a robust gold price environment.

VHM Limited has successfully raised $8.25 million through a discounted share placement, bolstering funds for its Goschen Project's next development phase. A subsequent $2 million Share Purchase Plan offers existing shareholders a chance to participate.

VHM Limited has launched a partially underwritten equity placement and share purchase plan to fund the development of its Goschen rare earths and mineral sands project, targeting production by late 2026.

Wide Open Agriculture secures $2.6 million via placement and plans a $500,000 Share Purchase Plan to fast-track its expansion into China and boost global sales of its lupin protein products.

Sparc Technologies is progressing its innovative green hydrogen pilot plant and graphene-based anti-corrosion trials, supported by a recent A$2.7 million capital raise to accelerate commercialisation and R&D.

Sparc Technologies has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at a 28.6% discount, aiming to raise up to $500,000 to fund key growth initiatives.

Latrobe Magnesium Limited has successfully closed an oversubscribed Share Purchase Plan, raising $836,800 to fund its Demonstration Plant operations in Victoria. This capital injection supports the company’s pioneering sustainable magnesium extraction efforts.

Proteomics International Laboratories Ltd is raising up to $5.5 million through a $4 million placement and a $1 million Share Purchase Plan at $0.37 per share, offering shareholders a discounted entry and free attaching options.

Bio-Gene Technology Limited has raised $2.1 million through a placement and launched a Share Purchase Plan to fund critical safety studies for its flagship insecticide Flavocide®, alongside development of Qcide and strategic initiatives.

Saturn Metals has significantly upsized its Share Purchase Plan to $9.25 million, raising total capital of $32.25 million to accelerate development of its Apollo Hill Gold Project and expand exploration in Western Australia.

Rox Resources has raised A$40 million through a strongly supported institutional placement to accelerate early development works at its high-grade Youanmi Gold Project, significantly de-risking the pathway to production.